TB-500 (Thymosin Beta-4) (10mg)
$124.00
TB-500 (Thymosin Beta-4) (10mg) is offered by Biotech Peptides for laboratory and analytical research. TB-500 is a synthetic 43-residue peptide derived from thymosin beta-4, studied in relation to cell migration, angiogenesis, and wound-repair signaling. 1153
-
Product: TB-500
-
Full name: Thymosin Beta-4
-
Listed quantity: 10 mg
-
Reference molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
TB-500 (Thymosin Beta-4) (10mg) for Laboratory Research
TB-500 (Thymosin Beta-4) (10mg) is offered by Biotech Peptides for laboratories investigating cell migration, angiogenesis, and wound-repair signaling. TB-500 is a synthetic 43-residue peptide derived from thymosin beta-4, a naturally occurring protein present in nearly all nucleated cells. 1153
For laboratories looking to buy TB-500, this listing identifies a 10 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.
Explore our research peptides for sale to review other laboratory-use listings.
TB-500 Product Information
| Property | Listing information |
|---|---|
| Product name | TB-500 |
| Full name | Thymosin Beta-4 |
| Listed quantity | 10 mg |
| Intended application | Laboratory and analytical research |
| Documentation inquiries | Include the product name and batch or lot number, where available |
The 10 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.
TB-500 Reference Molecular Characteristics
The following characteristics describe the TB-500 reference structure. They are not analytical confirmation of an individual commercial batch.
| Reference characteristic | Information |
|---|---|
| Peptide length | 43 residues |
| Reference sequence | Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH |
| Molecular formula | C₂₁₂H₃₅₀N₅₆O₇₈S |
| Approximate molecular weight | 4963 g/mol |
| CAS number | 77591-33-4 |
| Chemical class | Synthetic peptide derived from thymosin beta-4 |
The sequence, molecular formula, molecular weight, and CAS number are documented in the PubChem Timbetasin reference record and in the TB-500 research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1154
TB-500 and Angiogenesis Research
A review of thymosin beta-4 describes Tβ4 as a protein that promotes angiogenesis, tissue repair, and regeneration, and reduces scar formation. The same review notes that Tβ4 can promote cell migration and angiogenesis, regulate various cytokines, and inhibit apoptosis. 1110
A separate study of thymosin beta-4 in aged rodents reported that Tβ4 promotes angiogenesis and wound repair in both normal and aged rodents. The investigators also reported that Tβ4 promotes hair growth in normal and aged rodents. 1112
Read the review of thymosin beta-4 for the molecular mechanisms and evidence limitations.
Wound-Healing Research
A study of thymosin beta-4 in diabetic rats reported that Tβ4 accelerated wound closure, with significantly greater wound closing rates over control groups. The investigators also reported that Tβ4 promoted angiogenesis at the wound site, as seen by marked increases in endothelial cells and greater neovascularization. 1114
A separate study of thymosin beta-4 in corneal wound healing reported that Tβ4 promotes cell migration and wound healing, has anti-inflammatory properties, and suppresses apoptosis. 1113
These findings apply to specific animal models and wound-healing protocols. They do not establish that a commercial TB-500 batch improves wound healing, reduces inflammation, or produces a cosmetic effect in humans. 1112
Research Limitations
Published TB-500 research examines cell-based assays, rodent models, and limited wound-healing contexts. It does not establish that TB-500 improves tissue repair, reduces inflammation, promotes angiogenesis, or treats any condition. 1110
Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.
Documentation and Batch Verification
Before selecting TB-500 (Thymosin Beta-4) (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:
-
Product name and batch or lot identifier.
-
Manufacturer specifications and chemical form.
-
Salt state and counterion information, where applicable.
-
Identity-testing methods and reported results.
-
Purity-testing methods and supporting analytical data.
-
Quantity or peptide-content measurements, where required.
-
Product-specific storage and handling instructions.
Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.
For inquiries, provide “TB-500 (Thymosin Beta-4) (10mg),” the batch number where available, and the specific information your laboratory requires.
Storage and Handling
Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.
Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.
Frequently Asked Questions About TB-500 (Thymosin Beta-4) (10mg)
What is TB-500?
TB-500 is thymosin beta-4, a synthetic 43-residue peptide derived from a naturally occurring protein present in nearly all nucleated cells. 1110
Is TB-500 the same as thymosin beta-4?
Yes. TB-500 and thymosin beta-4 refer to the same molecule. 1110
Does TB-500 improve wound healing?
A study of thymosin beta-4 in diabetic rats reported that Tβ4 accelerated wound closure, with significantly greater wound closing rates over control groups. This does not establish that a commercial TB-500 batch improves wound healing in humans. 1112
What does the 10mg designation mean?
It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.
Does published research verify this product?
No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.
Where can I find delivery information?
Review our shipping information for current order-processing and delivery terms.
Research Use Only
TB-500 (Thymosin Beta-4) (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.
Review our Research-Use-Only Policy before ordering.
| Brand | Biotech Peptides |
|---|
Related products
Acetyl Hexapeptide-3 (Argireline) (200mg)
- Product: Acetyl Hexapeptide-3 (Argireline)
- Listed quantity: 200mg
- Alternative name: Acetyl Hexapeptide-8
- Sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂
- CAS number: 616204-22-9
- Research area: SNAP-25 and SNARE-complex interactions
ARA-290 (16mg)
ARA-290 (16mg) is offered by Biotech Peptides for laboratory and analytical research. Also called cibinetide, ARA-290 is a synthetic 11-residue peptide derived from the beta-helix domain of erythropoietin, studied in relation to innate repair receptor signaling and inflammatory pathways. 1181
-
Product: ARA-290
-
Alternative name: Cibinetide
-
Listed quantity: 16 mg
-
Reference molecular formula: C₅₁H₅₄N₁₆O₂₁
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Pal-GHK (Palmitoyl Tripeptide-1) (200mg) | Biotech Peptides
Pal-GHK (Palmitoyl Tripeptide-1) (200mg) is a synthetic, lipid-modified tripeptide listed for laboratory and analytical research involving peptide chemistry and skin-related research models.
Also known as Palmitoyl-Gly-His-Lys, Pal-GHK consists of a palmitoyl group attached to the N-terminus of the GHK tripeptide sequence. It has been investigated in research involving extracellular matrix components and topical cosmetic formulations. Reference molecular information:- Listed quantity: 200mg
- Peptide sequence: Gly-His-Lys (GHK)
- N-terminal modification: Palmitoyl group
- Molecular formula: C₃₀H₅₄N₆O₅
- Molecular weight: 578.8 g/mol
- CAS number: 147732-56-7
- Common name: Palmitoyl Tripeptide-1
PEG-MGF (Pegylated MGF) (5mg)
PEG-MGF (Pegylated MGF) (5mg) is offered by Biotech Peptides for laboratory and analytical research. PEG-MGF is a pegylated form of mechano growth factor, a synthetic 24-residue peptide derived from the E-domain of IGF-1Ec. 1002
-
Product: PEG-MGF
-
Full name: Pegylated Mechano Growth Factor
-
Listed quantity: 5 mg
-
Reference molecular formula: C₁₂₁H₂₀₀N₄₂O₃₉
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Pentapeptide-18 (Leuphasyl) (200mg) | Biotech Peptides
Pentapeptide-18 (Leuphasyl) (200mg) is a synthetic pentapeptide listed for laboratory and analytical research involving peptide structure and cosmetic-science research models.
Pentapeptide-18 is also known as Leuphasyl and is structurally related to leucine-enkephalin, with a D-alanine residue at position two. Its research background includes investigations into neurotransmitter signaling and topical cosmetic formulations. Reference molecular information:- Listed quantity: 200mg
- Sequence: H-Tyr-D-Ala-Gly-Phe-Leu-OH
- Molecular formula: C₂₉H₃₉N₅O₇
- Molecular weight: Approximately 569.6 g/mol
- CAS number: 64963-01-5
- Alternative name: Leuphasyl
PT-141 (Bremelanotide) (10mg)
PT-141 (Bremelanotide) (10mg) is offered by Biotech Peptides for laboratory and analytical research. Also called bremelanotide, this synthetic cyclic heptapeptide is a melanocortin receptor agonist studied in relation to MC1R, MC3R, and MC4R signaling.accessdata.fda+2
-
Product: PT-141 (Bremelanotide)
-
Alternative name: Bremelanotide
-
Listed quantity: 10 mg
-
Reference molecular formula: C₅₀H₆₈N₁₄O₁₀
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
